Developing an international Pseudomonas aeruginosa reference panel

Anthony De Soyza1, Amanda J Hall, Eshwar Mahenthiralingam

  • 1Institute of Cellular Medicine, Newcastle University, Newcastle, U.K.

Microbiologyopen
|November 12, 2013
PubMed

Insights

This study introduces a diverse Pseudomonas aeruginosa reference panel to aid research. This resource will advance understanding of virulence and antimicrobial resistance in cystic fibrosis patients and other populations.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen, particularly in cystic fibrosis (CF) patients, known for its antimicrobial resistance and diverse strains.
  • Current research often overlooks the full diversity of P. aeruginosa, focusing on a limited number of strains, which hinders a comprehensive understanding of its virulence and pathogenesis.

Purpose of the Study:

  • To establish a standardized reference panel of Pseudomonas aeruginosa strains that accurately reflects the species' diversity.
  • To provide a consolidated resource for the research community to accelerate the discovery of virulence factors and improve understanding of P. aeruginosa infections.

Main Methods:

  • A curated panel of 43 P. aeruginosa strains was assembled.
  • The panel includes commonly studied clones, transmissible strains, sequential isolates from CF patients, and strains representing diverse serotypes, genotypes, and geographic origins.

Main Results:

  • The developed panel encompasses a broad spectrum of P. aeruginosa diversity, including clinical and environmental isolates.
  • This resource facilitates comparative studies on virulence, pathogenesis, and antimicrobial resistance across different P. aeruginosa populations.

Conclusions:

  • The P. aeruginosa reference panel serves as a valuable community resource for advancing research into virulence determinants and pathogenesis.
  • This standardized collection of isolates will aid in the development and testing of novel therapeutic agents against P. aeruginosa infections.

Related Concept Videos